Skip to main content

Search

15 result(s) for 'author#J. Stuart Elborn' within BMC

Page 1 of 1

Sort by: Relevance | Date

  1. The impact of bronchiectasis on sedentary behaviour and physical activity is unknown. It is important to explore this to identify the need for physical activity interventions and how to tailor interventions to...

    Authors: Judy M Bradley, Jason J Wilson, Kate Hayes, Lisa Kent, Suzanne McDonough, Mark A Tully, Ian Bradbury, Alison Kirk, Denise Cosgrove, Rory Convery, Martin Kelly, Joseph Stuart Elborn and Brenda O’Neill
    Citation: BMC Pulmonary Medicine 2015 15:61
  2. Current guidelines for the management of bronchiectasis (BE) highlight the lack of evidence to recommend mucoactive agents, such as hypertonic saline (HTS) and carbocisteine, to aid sputum removal as part of s...

    Authors: Judy Martina Bradley, Rohan Anand, Brenda O’Neill, Kathryn Ferguson, Mike Clarke, Mary Carroll, James Chalmers, Anthony De Soyza, Jamie Duckers, Adam T. Hill, Michael R. Loebinger, Fiona Copeland, Evie Gardner, Christina Campbell, Ashley Agus, Alistair McGuire…
    Citation: Trials 2019 20:747
  3. Cystic fibrosis is one of the most common life-limiting inherited disorders. Its clinical impact manifests chiefly in the lung, pancreas, gastrointestinal tract and sweat glands, with lung disease typically be...

    Authors: Sally H Pattison and J Stuart Elborn
    Citation: Genome Medicine 2010 2:88
  4. Pseudomonas aeruginosa is considered to grow in a biofilm in cystic fibrosis (CF) chronic lung infections. Bacterial cell motility is one of the main factors that have been connected with P. aeruginosa adherence ...

    Authors: Elena Deligianni, Sally Pattison, Daniel Berrar, Nigel G Ternan, Richard W Haylock, John E Moore, Stuart J Elborn and James SG Dooley
    Citation: BMC Microbiology 2010 10:38
  5. Regular physical activity (PA) is a valued part of cystic fibrosis (CF) care. Although the accelerometer, SenseWear Armband (SWA), accurately measures habitual PA in CF, it is mostly used for research purposes...

    Authors: Daniela Savi, Luigi Graziano, Barbara Giordani, Stefano Schiavetto, Corrado De Vito, Giuseppe Migliara, Nicholas J. Simmonds, Paolo Palange and J. Stuart Elborn
    Citation: BMC Pulmonary Medicine 2020 20:285
  6. Staphylococcus aureus produces a set of proteins which act both as superantigens and toxins. Although their mode of action as superantigens is well understood, little is known about their effects on airway epithe...

    Authors: Garrett J O'Brien, Gareth Riddell, J Stuart Elborn, Madeleine Ennis and Grzegorz Skibinski
    Citation: Respiratory Research 2006 7:115
  7. Chronic infection and concomitant airway inflammation is the leading cause of morbidity and mortality for people living with cystic fibrosis (CF). Although chronic infection in CF is undeniably polymicrobial, ...

    Authors: Leah Cuthbertson, Alan W. Walker, Anna E. Oliver, Geraint B. Rogers, Damian W. Rivett, Thomas H. Hampton, Alix Ashare, J. Stuart Elborn, Anthony De Soyza, Mary P. Carroll, Lucas R. Hoffman, Clare Lanyon, Samuel M. Moskowitz, George A. O’Toole, Julian Parkhill, Paul J. Planet…
    Citation: Microbiome 2020 8:45
  8. The abnormal regulation of neutrophil apoptosis may contribute to the ineffective resolution of inflammation in chronic lung diseases. Multiple signalling pathways are implicated in regulating granulocyte apop...

    Authors: Vanessa Brown, J Stuart Elborn, Judy Bradley and Madeleine Ennis
    Citation: Respiratory Research 2009 10:24
  9. We aimed to determine adherence to inhaled antibiotics, other respiratory medicines and airway clearance and to determine the association between adherence to these treatments and health outcomes (pulmonary ex...

    Authors: Amanda R McCullough, Michael M Tunney, Alexandra L Quittner, J Stuart Elborn, Judy M Bradley and Carmel M Hughes
    Citation: BMC Pulmonary Medicine 2014 14:107
  10. Biomarkers of inflammation predictive of cystic fibrosis (CF) disease outcomes would increase the power of clinical trials and contribute to better personalization of clinical assessments. A representative pat...

    Authors: Theodore G. Liou, Frederick R. Adler, Natalia Argel, Fadi Asfour, Perry S. Brown, Barbara A. Chatfield, Cori L. Daines, Dixie Durham, Jessica A. Francis, Barbara Glover, Theresa Heynekamp, John R. Hoidal, Judy L. Jensen, Ruth Keogh, Carol M. Kopecky, Noah Lechtzin…
    Citation: BMC Medical Research Methodology 2019 19:88
  11. The potential pathogenic role of Stenotrophomonas maltophilia in lung disease and in particular in cystic fibrosis is unclear. To develop further understanding of the biology of this taxa, the taxonomic position,...

    Authors: Ad C. Fluit, Jumamurat R. Bayjanov, María Díez Aguilar, Rafael Cantón, Stuart Elborn, Michael M. Tunney, Jelle Scharringa, Barry J. Benaissa-Trouw and Miquel B. Ekkelenkamp
    Citation: BMC Microbiology 2022 22:129
  12. Bronchiectasis is a disease associated with chronic progressive and irreversible dilatation of the bronchi and is characterised by chronic infection and associated inflammation. The prevalence of bronchiectasi...

    Authors: Ravishankar Chandrasekaran, Micheál Mac Aogáin, James D. Chalmers, Stuart J. Elborn and Sanjay H. Chotirmall
    Citation: BMC Pulmonary Medicine 2018 18:83
  13. Low patient adherence to treatment is associated with poorer health outcomes in bronchiectasis. We sought to use the Theoretical Domains Framework (TDF) (a framework derived from 33 psychological theories) and...

    Authors: Amanda R. McCullough, Cristín Ryan, Brenda O’Neill, Judy M. Bradley, J. Stuart Elborn and Carmel M. Hughes
    Citation: BMC Health Services Research 2015 15:342
  14. Cystic fibrosis is the most common genetically determined, life-limiting disorder in populations of European ancestry. The genetic basis of cystic fibrosis is well established to be mutations in the cystic fib...

    Authors: Malcolm Brodlie, Iram J. Haq, Katie Roberts and J. Stuart Elborn
    Citation: Genome Medicine 2015 7:101
  15. Bacteria have been extensively implicated in the development of smoking related diseases, such as COPD, by either direct infection or bacteria-mediated inflammation. In response to the health risks associated ...

    Authors: Deirdre F. Gilpin, Katie-Ann McGown, Kevin Gallagher, Jose Bengoechea, Amy Dumigan, Gisli Einarsson, J. Stuart Elborn and Michael M. Tunney
    Citation: Respiratory Research 2019 20:267